09-005
Showing 1 - 25 of 3,020
Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)
Not yet recruiting
- Schizophrenia
- Schizoaffective Disorder
- (no location specified)
Mar 24, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
Congenital Adrenal Hyperplasia Trial run by the (Hydrocortisone)
Completed
- Congenital Adrenal Hyperplasia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 17, 2022
COVID-19 Trial in India (101-PGC-005, Dexamethasone)
Recruiting
- COVID-19
-
Srikakulam, Andhra Pradesh, India
- +4 more
Jan 31, 2023
Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)
Active, not recruiting
- Glucocorticoids Toxicity
- +3 more
-
Bangalore, Karnataka, IndiaICBio Clinical Research Pvt. Ltd.
Dec 13, 2022
MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))
Withdrawn
- MPS I
- +2 more
- SIG-005 (hIDUA Producing Spheres)
-
Porto Alegre, Brazil
- +2 more
Dec 16, 2022
Appraising Medical Trial Experiences of Ovarian Cancer Patients
Not yet recruiting
- Ovarian Cancer
- (no location specified)
Mar 24, 2023
Engagement Dynamics Among Individuals Impacted by Bladder Cancer
Not yet recruiting
- Bladder Cancer
-
San Francisco, CaliforniaPower Life Sciences
Aug 18, 2023
Glabellar Frown Lines Trial in Miami (AI-09, Vehicle)
Recruiting
- Glabellar Frown Lines
- AI-09
- Vehicle
-
Miami, FloridaBaumann Cosmetic & Research Institute
Oct 11, 2022
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Sepsis Trial in Nanjing (SY-005, Placebo)
Recruiting
- Sepsis
- SY-005
- Placebo
-
Nanjing, Jiangsu, ChinaZhongda Hospital，Affiliated to Southeast University
Feb 27, 2022
Amyotrophic Lateral Sclerosis Trial in Boston (Trehalose)
Temporarily not available
- Amyotrophic Lateral Sclerosis
-
Boston, MassachusettsSean M. Healey & AMG Center for ALS Neurological Clinical Resear
Dec 14, 2022
Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)
Not yet recruiting
- Alzheimer's Disease
- SLS-005
- Placebo
-
Heidelberg, Victoria, Australia
- +2 more
Dec 23, 2022
Advanced Solid Tumor or Lymphoma Trial in United States (BJ-005)
Recruiting
- Advanced Solid Tumor or Lymphoma
- BJ-005
-
Phoenix, Arizona
- +5 more
Jul 19, 2022
Acne Vulgaris Trial in Hawthorne (Trifarotene Cream 0.005%, Placebo, AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories))
Completed
- Acne Vulgaris
- Trifarotene Cream 0.005%
- +2 more
-
Hawthorne, New YorkTaro Pharmaceuticals USA Inc.
Sep 27, 2023
Advanced Solid Tumor Trial (EMB-09)
Not yet recruiting
- Advanced Solid Tumor
- EMB-09
- (no location specified)
Feb 22, 2022
Spinocerebellar Ataxia Type 3 Trial in Los Angeles, Tampa (SLS-005, Placebo)
Recruiting
- Spinocerebellar Ataxia Type 3
- SLS-005
- Placebo
-
Los Angeles, California
- +1 more
Aug 4, 2022
Oral Squamous Cell Carcinoma Trial in Tampere (Punch biopsy)
Recruiting
- Oral Squamous Cell Carcinoma
- Punch biopsy
-
Tampere, Pirkanmaa, FinlandTampere University Hospital
Jun 5, 2023
